# Efficacy and Safety of Omega-3 Lipid Therapy in Pediatric Patients With Parenteral Nutrition-Associated Liver Disease

> **NCT01739517** · PHASE2 · UNKNOWN · sponsor: **Amarnath, Rathna, M.D.** · enrollment: 20 (estimated)

## Conditions studied

- Short Bowel Syndrome
- Cholestasis

## Interventions

- **DRUG:** Omegaven Therapy

## Key facts

- **NCT ID:** NCT01739517
- **Lead sponsor:** Amarnath, Rathna, M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-03
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2012-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01739517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01739517, "Efficacy and Safety of Omega-3 Lipid Therapy in Pediatric Patients With Parenteral Nutrition-Associated Liver Disease". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01739517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*